Term
Amyotrophic Lateral Sclerosis |
|
Definition
progressive weakness & wasting of muscles, destruction of motor neurons |
|
|
Term
|
Definition
progressive loss of brain function (memory loss, confusion, & dementia) |
|
|
Term
|
Definition
progressive dementia and involuntary spasmodic movement |
|
|
Term
|
Definition
progressive weakness, visual disturbances, mood alteration, cognitive deficits |
|
|
Term
|
Definition
Progressive loss of dopamine causes tremor, muscle rigidity, abnormal movement and posture |
|
|
Term
|
Definition
|
|
Term
Parkinson’s Disease Symptoms |
|
Definition
|
|
Term
Parkinson’s Disease
Pathophysiology
|
|
Definition
Degeneration and destruction of the dopamine producing neurons in the substantia nigra
The substantia nigra neurons supply dopamine to the corpus striatum that controls unconscious muscle movement
Neurotransmitters must be balanced in the corpus striatum (dopamine & acetylcholine)
Drug therapy focuses on increasing dopamine and blocking the effects of acetylcholine |
|
|
Term
Dopaminergics
What do they do? |
|
Definition
Either restore dopamine function or stimulate dopamine receptors balancing dopamine and acetylcholine
Drugs of choice
Levadopa (l-dopa, Laradopa) – prototype
Carbidopa – levadopa (Sinemet)
Dopamine agonists
Ropinirole (Requip)
May be more effective in controlling dyskinesia |
|
|
Term
|
Definition
-
Actions: Restores neurotransmitter dopamine
-
Administration alerts: Administer as ordered, do not stop taking abruptly (can cause an increase in acetocoline which causes parkinsonism)
-
Pharmacokinetics - Onset 30 min peak 1-3 hrs, half life 1 hr (can take weeks to see change)
-
Adverse effects - Purposeless movement, uncontrolled movement, loss of appetite, N&V, orthostatic hypotension(FALLS)
-
Drug interactions: Tricyclic antidepressants, MAOIs, antihypertensives, anticonvulsants, antacids, pyridoxine (B-6) + ***Kava
-
Lab tests – liver enzymes and BUN
|
|
|
Term
Anticholinergics
(Cogentin) |
|
Definition
Block the effects of actylcholine in the corpus striatum Earliest drugs used to treat Parkinson’s disease.
Benztropine mesylate (cogentin) (.5-1 mg/day) Sedation, nausea, constipation, dry mouth, blurred vision, drowsiness, dizziness, hypotension, tachycardia, nervousness
Nursing Considerations: Careful monitoring of condition and adverse reactions to medication, Monitor B/P and heart rate, Muscle twitching and mood changes may indicate drug toxicity – report to HCP at once
Client Education
* Increase fiber and fluid intake
*Avoid foods high in pyridoxine (OTC, fortified foods)
*Report muscle spasms, spasmodic winking, and increase in bradykinesia
*Takes up to six months for therapeutic levels to be achieved
*Do not stop taking medicine abruptly
*Change positions slowly
|
|
|
Term
|
Definition
-
Responsible for 70% of all dementia
-
Progressive memory loss, confusion, inability to think or communicate effectively
-
4th leading cause of death in the US
-
Etiology unknown
-
Familial form; environmental, immunological, and nutritional factors, Structural damage in the brain- loss in number and function of neurons, Deficit in tasks that require the neurotransmitter acetycholine.
Symptoms
Impaired Memory Loss Confusion and disorientation
Inability to recongnize family and friends Aggressive Behavior
Depression Psychosis Anxiety
|
|
|
Term
Donepezil
(Aricept)
Alzheimer's Disease |
|
Definition
Pharmacokinetics
<20 minutes, peak 3-4 hrs, half life 70 hours
Actions/uses
Enhances the effects of acetylcholine in the neurons that have not been damaged, effects may not be seen for six months, effects modest at best
Administration
Give at bedtime |
|
|
Term
Acetylcholinesterase Inhibitors
Donepezil (Aricept)
|
|
Definition
-
Pharmacokinetics <20 minutes, peak 3-4 hrs, half life 70 hours
-
Actions/uses Enhances the effects of acetylcholine in the neurons that have not been damaged, effects may not be seen for six months, effects modest at best
-
Administration Give at bedtime NEED REGULAR SCHEDULE
-
Adverse effects V&D, dark urine, insomnia, syncope, depression, HA, irritability, muscle cramps, arthritis, bone fractures, fatigue, chest pain, >libido, hot flashes, incontinence, dehydration, blurred vision
-
Interactions- phenobarb, phenytoin, dexamethazone, and rifampin may speed metabolism (speed the metabolism of Aricept)
-
Nursing Considerations Careful monitoring of condition and adverse reactions to medication Monitor B/P and heart rate Monitor for changes in mental status, mood changes, dizziness, confusion, insomnia, anorexia, N&V
-
Client Education Take drug as prescribed Know and report major side effects Report changes in mental status or mood Takes up to six months for therapeutic levels to be achieved Frequent drinks of cool liquid or sugar free hard candy, or sugar free gum for dry mouth Increase fiber and fluid intake
|
|
|
Term
|
Definition
Associated with excessive use or local injury, antipsychotic drugs, epilepsy, hypocalcemia pain, and neurological disorders
Symptoms:
|
|
|
Term
Centrally Acting
Skeletal Muscle Relaxants |
|
Definition
Probably inhibit upper motor neuron activity
* CNS depression
* Alter spinal reflexes
Commonly Used Drugs:
1: Baclofen (Lioresal)
2. Cyclobenzaprine (cycloflex, flexeril)
3. Tizanidine (Zanaflex)
4. Benzodiazepines (Valium, Klonopin, Ativan) (Seizure Control) |
|
|
Term
Cyclobenzaprine
(cycloflex, flexeril)
Muscle Relaxant |
|
Definition
Actions/Use: Depresses motor activity at the brain stem.
Increases circulating levels of norepinephrine.
Not effective for CP or diseases of the brain or spinal cord.
Administration: Not recommended for children
Maximum effects may take up to 2 weeks
Pharmacokinetics: Onset 1 hour Peak 3-8 hrs/duration 12-14 hrs Half life 1-3 days
Adverse effects: Drowsiness, blurred vision, dizziness, dry mouth, rash, tachycardia
Interactions: Alcohol, other CNS depressants, MAOIs |
|
|
Term
|
Definition
Usually secondary to cerebral cortex injury:
(CP, head and spinal cord injury or lesion, stroke.)
|
|
|
Term
|
Definition
Centrally acting (CNS)
Baclofen (lioresal)
Diazapam (valium)
Direct acting (on muscle)
Dantrolene Sodium (Dantrium)
Botulinum toxin (botox)
Quinine sulfate |
|
|
Term
Dantrolene Sodium (Dantrium)
Antispasmodics |
|
Definition
Action/Uses Interferes with the release of calcium ions from inside skeletal muscle cells Spinal cord injury, stroke, CP, MS,
Administration Use oral solution within days (no preservative) IV – high PH, very irritating Dantrolene Sodium (Dantrium) – prototype
Pharmacokinetics Onset 1-2 hours Peak 5 hours/ duration varies Half life 4-8 IV, 8-9 PO
Adverse effects Muscle weakness, dry mouth, drowsiness, dizziness, nausea, diarrhea, tachycardia, erratic B/P, urinary retention, photosensitivity
Interactions Not with OTC cough preparations or antihistamines Alcohol Other CNS depressants
Nursing Considerations Careful monitoring of client conditions Monitor lab tests when indicated May need assistance in taking meds. (because of spasticity)
Client Education Avoid driving and other potentially hazardous activity Report changes in sensorium, chest pain, palpitations, dyspnea, fatigue, visual disturbances, urine retention Other medications, OTC, herbals DC alcohol ROM exercises Do not DC medicine abruptly – may cause seizures |
|
|
Term
|
Definition
-
Consists of glands that secrete hormones
-
Maintains homeostasis using hormones as chemical messengers *Secreted in response to changes in internal environment
-
Hormone release commonly controlled by negative feedback *One hormone may control another
-
Negative Feedback: *Common for last hormone in a pathway to provide feedback * Turns off secretion from first hormone. * Prevents over responses by endocrine system.
-
Hypothalamus and Pituitary Glands: Control many other glands
-
Hypothalamus secretes releasing hormones (Directs anterior pituitary gland as to which hormones should be released)
-
Hypothalamus sends nerve signals (Posterior pituitary releases hormones)
|
|
|
Term
|
Definition
|
|
Term
Pituitary and Hypothalamic Hormones |
|
Definition
Only a few hormones have clinical application
Commonly used for replacement are
*** Prolactin, oxytocin **
1) Corticotropin, growth hormone
2) Antidiuretic hormone (ADH) |
|
|
Term
|
Definition
Stimulates growth and metabolism
**Deficiency results in dwarfism
Recombinant DNA technology has produced pharmacotherapy Somatrem (Protropin) and Somatropin (Humatrope) "used most often"
**Recently approved to treat small stature associated with normal levels of growth hormone (GH)
Excess secretion results in acromegaly (adults) |
|
|
Term
Antidiuretic Hormone (ADH) |
|
Definition
Conserves water in body
**Diabetes insipidus is caused by deficiency of ADH (uncontrolled diaresis, Major fluid loss.. low ADH)
Most common form of ADH: desmopressin (DDAVP)
***Long duration of action (20 hours) *** Forms: nasal spray, oral, intravenous, subcutaneous
Other drugs: vasopressin (Pitressin) and lypressin (Diapid)
|
|
|
Term
Anterior Pituitary Hormone
vasopressin injection (Pitressin) |
|
Definition
Mechanism of action: causes renal collecting tubules to increase their permeability to water. & Enhances water reabsorption
Primary use: treatment of diabetes insipidus
Adverse effects: hypertension! * Can precipitate angina episodes and myocardial infarction in clients with coronary artery disease. * Excessive fluid retention can cause water intoxication.
Nursing Considerations: Assess for electrolyte imbalances, Assess for changes in specific gravity and fluid intake. Monitor serum sodium and potassium levels. Monitor urinary specific gravity, routine urinalysis. Monitor body weight and fluid intake/output. Assess vital signs, especially blood pressure and pulse |
|
|
Term
|
Definition
Secretes thyroxine (T4) and triiodothyronine (T3)
**Control basal metabolic rate and affect every cell in body
Parafollicular cells in thyroid secrete calcitonin
**Responsible for calcium homeostasis
Follicular cells secrete thyroid hormone
***Thyroxine (T4) and triiodothyronine (T3)
***Iodine essential for synthesis of T4 and T3
Negative-feedback loop controls secretion
***Low thyroxine levels signal hypothalamus to release thyroid-releasing hormone (TRH)
*** Signals pituitary to release thyroid-stimulating hormone (TSH) |
|
|
Term
Hypothyroidism in Adults (Myxedema) |
|
Definition
-
More severe symptoms include: Slurred speech, bradycardia, weight gain, Decreased sense of taste and smell, Intolerance to cold environments
|
|
|
Term
Pharmacotherapy for hypothyroidism
levothyroxine (Synthroid) |
|
Definition
Mechanisms of action: same as those of thyroid hormone (how T3 T4 acts on the body naturally)
Primary use: drug of choice for replacement therapy in clients with low thyroid function
Adverse effects: hyperthyroidism, palpitations, dysrhythmias
***(Anxiety, insomnia, weight loss, heat intolerance Menstrual irregularities and osteoporosis in women <- these are signs of hyperthyroidism)
Nursing Considerations: ***(these are assesing for TOO MUCH stynthroid) Assess client’s weight and vital signs Assess tachycardia, irregular heart rate, hypertension Assess nervousness, weight loss, diarrhea, heat intolerance. Monitor clients with impaired renal function closely
***(these are assessing for TOO LITTLE synthroid)Monitor for excess fatigue, slow speech, hoarseness or slow pulse May indicate under dosage |
|
|
Term
|
Definition
Most common type: is Grave’s disease
Goal: is to lower activity of thyroid
Symptoms: Increased body metabolism Tachycardia, weight loss Elevated body temperature, anxiety.
Treatment:
1: Administer thioamides, which decrease activity of thyroid gland: Propylthiouracil(PTU) and methimazole (Tapazole).
2: Radioactive iodide that kills overactive thyroid cells. SUCH AS: Sodium iodide-131, Lugol’s solution
Goal is to lower activity of thyroid gland
|
|
|
Term
Antithyroid Pharmacotherapy
propylthiouracil (PTU)
(for hyperthyroidism) |
|
Definition
Mechanism of action: to interfere with synthesis of T3 and T4 in thyroid gland. Also prevents conversion of T4 to T3 in target tissues
Adverse effects: symptoms of hypothyroidism....
***Rash and transient leucopenia are most common side effects
***Small percentage of clients experience agranulocytosis
Nursing Considerations:
Monitor vital signs
Monitor thyroid-function tests
Monitor for signs of infection, including CBC and WBC count
Monitor weight at least weekly
Monitor for drowsiness |
|
|
Term
|
Definition
Secretes glucocorticoids:
1) Mobilize body for long-term stress
2) Influence carbohydrate, lipid, and protein metabolism in most cells
Secretes mineralocorticoids:
1)Aldosterone promotes sodium reabsorption and potassium secretion
Secretes gonadocorticoids
1)Male sex hormones (androgens) |
|
|
Term
|
Definition
|
|
Term
Control of Glucocorticoids |
|
Definition
Hypothalamus releases corticotropin-releasing factor (CRF)
Adrenal cortex releases glucocorticoids
**When cortisol level rises, negative-feedback mechanism shuts off further release of glucocorticoids |
|
|
Term
Adrenocortical Insufficiency
(Addison’s Disease) |
|
Definition
Primary adrenocortical insufficiency
It is rare; deficient of both glucocorticoids and mineralocorticoids
Symptoms:
*Hypoglycemia, fatigue, hypotension
*Increased skin pigmentation
*GI disturbances: anorexia, vomiting, diarrhea
*Low plasma cortisol, accompanied by high plasma ACTH levels |
|
|
Term
Adrenal Drugs — Glucocorticoids
hydrocortisone
(Aeroseb-HC, Alphaderm) |
|
Definition
Mechanism of action: acts as synthetic corticosteroid
Primary use: drug of choice for treating adrenocortical insufficiency
Adverse effects: sodium and fluid retention
CNS effects: insomnia, anxiety, headache, vertigo, confusion, depression
***Hypertension, tachycardia, peptic ulcer disease, Cushing’s syndrome (Can occur with long-term therapy)
Nursing Considerations: Assess: vital signs for temperature and blood-pressure elevations
Monitor: potassium, T3, T4, glucose levels
***Clients on long-term glucocorticoid therapy Monitor for osteoporosis and elevated serum cholesterol levels
***Assess for signs and symptoms of Cushing’s syndrome
Monitor: skin and mucous membranes for lacerations, abrasions, or break in integrity
Monitor: GI status for peptic ulcer development
Monitor: serum electrolytes
Monitor: changes in musculoskeletal system
Monitor: emotional stability |
|
|
Term
|
Definition
Caused by long-term administration of glucocorticoids
Signs and symptoms Moon face, buffalo hump, mood and personality disorders
Also: Hyperglycemia, Na and fluid retention, bruises and petichia, thin skin, osteoporosis, fate deposits on back, thin extremities |
|
|
Term
|
Definition
Used to treat severe Cushing’s syndrome:
Antiadrenal drugs NOT curative:
|
|
|